Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by availability of reimbursement for bgm devices, growing prevalence of diabetes, and increasing number of product launches.
The blood glucose monitoring system market is segmented as below:
By Product
- Self monitoring
- Continuous glucose monitoring devices
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the blood glucose monitoring system market covers the following areas:
- Blood Glucose Monitoring System Market sizing
- Blood Glucose Monitoring System Market forecast
- Blood Glucose Monitoring System Market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
Executive Summary
The following companies are recognized as the key players in the global blood glucose monitoring system market: Abbott Laboratories, ACON Laboratories Inc., ARKRAY Inc., B.Braun SE, Dexcom Inc., DiaMonTech AG, F. Hoffmann La Roche Ltd., GlySens Inc., i-SENS, Inc., Indigo Diabetes NV, Intuity Medical Inc., Koninklijke Philips N.V., LifeScan IP Holdings LLC, Medtronic Plc, Nipro Corp., Ok Biotech Co Ltd., PHC Holdings Corp., Prodigy Diabetes Care LL, WaveForm Technologies Inc., and Ypsomed Holding AG.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is rising demand for continuous blood glucose monitoring (CGM) devices."
According to the report, one of the major drivers for this market is the availability of reimbursement for bgm devices.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- ACON Laboratories Inc.
- ARKRAY Inc.
- B.Braun SE
- Dexcom Inc.
- DiaMonTech AG
- F. Hoffmann La Roche Ltd.
- GlySens Inc.
- i-SENS Inc.
- Indigo Diabetes NV
- Intuity Medical Inc.
- Koninklijke Philips N.V.
- LifeScan IP Holdings LLC
- Medtronic Plc
- Nipro Corp.
- Ok Biotech Co Ltd.
- PHC Holdings Corp.
- Prodigy Diabetes Care LL
- WaveForm Technologies Inc.
- Ypsomed Holding AG